davlz22 (Post 20209) I was thinking along similar lines to those you have just stated, and intended to post something as follows:
Kozel, do you have any thoughts on a view that might say that within approximately eight weeks (once big pharmas have had time to think about the Cetilistat summary results announced earlier this month and they have more detailed data on their desks, increasing expectation of a deal; plus the Takeda results and details of a milestone payment are likely to be out) there is a likelihood of increasing investor demand for the stock and upward movement in the price?